Pharmaceutical Technology-12-02-2020

Pharmaceutical Technology

E-beam Process Could Offset Sterilization Constraints

December 02, 2020

Operations

44

12

Sterilization of primary packaging is important for vaccines.

Pandemic Brings Major Changes to FDA and Drug Development in 2020

December 02, 2020

Regulatory Watch

44

12

Manufacturers and regulators accelerate R&D and production of new vaccines and therapies.

Inspecting GMP at a Distance

December 02, 2020

Regulatory Watch

44

12

The success of virtual GMP inspections performed during the pandemic may lead to more flexible opportunities in the future.

Bio/Pharma, People, Perseverance, and Hope

December 02, 2020

From The Editor

44

12

After a difficult year, bio/pharma science delivers promising results.

The COVID-19 Vaccine Blind Spot

December 02, 2020

From The Editor

44

12

Transparency and open-dialogue are vital to sway the vaccine-hesitant community.

Impact of Pandemic on Permanent Procedures

December 02, 2020

Ask the Expert

44

12

Virtual audits, virtual training, and more robust quality agreements may become positive impacts on the industry, says Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates.

Intensifed Process Offers Cost-Effective Viral Vector Manufacturing

December 02, 2020

Manufacturing

44

12

Pharmaceutical Technology spoke with Tania Pereira Chilima, Deputy CTO at Univercells Technologies about their technology and how it can be used in viral vector manufacturing, which is needed for production of some of the COVID-19 vaccine candidates.